SCINOPHARM TAIWAN LTD.
台灣神隆股份有限公司
Leave your email for change alerts (optional)
1997Founded
NT$7.9BPaid-in capital
1Plants
4Certifications
10Patents
NT$1–5BRevenue band
- Unified Business No.
- 16130161
- Industry
- Pharmaceuticals & Medicinal Chemicals (273)
- Main products
- Pharmaceuticals & medicinal chemicals (276)
- Location
- NO.1, NAN-KE 8TH ROAD, SOUTHERN TAIWAN SCIENCE PARK, SHAN-HUA, TAINAN CITY 74144,TAIWAN, R.O.C
Tainan City (8,491) · Shanhua Dist. (160) - Listing
- Listed (TWSE) (1,087) 1789
- Organisation type
- Company Limited by Shares
- Founded
- 1997-11-11
- Paid-in capital
- NT$ 7,907,392,220
- Representative
- Lo Chih-hsien
- Phone
- 06-5052888
- Website
- https://www.scinopharm.com/tw/
- Exporter
- Yes — registered with the Trade Administration
- Annual revenue band
- NT$1–5B
- Ownership
- Group subsidiary / corporate-held · UNI-PRESIDENT ENTERPRISES CORP.、TAIWAN SUGAR CORPORATION、TAINAN SPINNING CO., LTD.、Tung Yi International Development Co., Ltd.、Tainan Textile Co., Ltd.
- North American market
- FDA drug establishment registration
- Representative tenure
- In office since 2017-08 (9 yrs); last handover 2017-08
- Growth & profitability
- Revenue 2026-09 YoY +74.4%, year-to-date -5.7%
Gross margin 26.6%, operating margin -4.3%, net margin -1.4% (2026-Q2 YTD) - Compliance record
- Environmental penalties: 2 case(s) in 5 years, latest 2022-08-30, fines NT$ 66,000 (industrial waste; toxic chemicals)
Occupational safety penalties: 1 case(s) in 5 years, latest 2025-07-15, fines NT$ 100,000 (Art. 184) — matched by company name
Certifications 4
- GMP (261)Self-reported
- ISO 14064 (319)Self-reported
- ISO 14067 (83)Self-reported
- TOSHMS (271)Self-reported
Patents 10
- 2026 Improved process for alectinib or salt thereof
- 2025 Preparation method of glucagon-like peptide-1
- 2023 Method for preparing cedazuridine
North American market evidence 1
- FDA drug establishment registration 3002840477 12/31/2026
ANALYSIS; API MANUFACTURE; MANUFACTURE and more (6)
Similar companies 10
- YUNG ZIP CHEMICAL IND. CO., LTD. · Taichung City Listed (TPEx) NT$0.5–1B
Shared: GMP, Other chemical materials manufacturing n.e.c., Active pharmaceutical ingredient (API) manufacturing - Taiwan Bio-Manufacturing Corporation · Hsinchu County NT$1–5B estimated
Shared: Active pharmaceutical ingredient (API) manufacturing - PROCHEM PHARMTECH CO., LTD. · Tainan City < NT$20M estimated
Shared: Active pharmaceutical ingredient (API) manufacturing - INTECH BIOPHARM LTD. · Hsinchu County Listed (TPEx) NT$20–100M
Shared: GMP, Other professional, scientific & technical services n.e.c. - SAN YUEH CHEMICAL CORPORATION · Chiayi County < NT$20M estimated
Shared: Other chemical materials manufacturing n.e.c. - SAVIOR LIFETEC CORPORATION TAINAN BRANCH · Tainan City Listed (TPEx) NT$1–5B
Shared: GMP, Other chemical materials manufacturing n.e.c., Active pharmaceutical ingredient (API) manufacturing - Tanvex BioPharma, INC., Taiwan Branch(CAYMAN ISLANDS) · Hsinchu County Listed (TWSE) NT$0.5–1B
Shared: GMP, Other professional, scientific & technical services n.e.c. - CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. · New Taipei City Listed (TWSE) NT$1–5B
Shared: GMP, Active pharmaceutical ingredient (API) manufacturing - Reliance Biosciences Incorporated · New Taipei City NT$20–100M estimated
Shared: Other professional, scientific & technical services n.e.c. - DELTA SYNTHETIC CO., LTD. · New Taipei City < NT$20M estimated
Shared: Other chemical materials manufacturing n.e.c.